HomeFUNDING

Category: FUNDING

Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.

Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.

Phenomix Sciences Raises $7.8M in...

May 16, 2024

Funding will accelerate the commercialization and adoption of the MyPhenome™ test in the obesity specialist market and the wider industry. The MyPhenome test equips physicians with essential tools to develop effective treatment plans including lifestyle and diet intervention as well as medication and/or procedure recommendations reports Phenomix Sciences.

R3 Vascular Announces $87 Million...

May 9, 2024

R3 Vascular will use the proceeds to support the ELITE FDA IDE pivotal trial of its best-in-class bioresorbable scaffold, MAGNITUDE®, for below-the-knee (BTK) PAD.

Phenomix Sciences Raises $7.8M in Funding to Accelerate Adoption of Obesity Precision Medicine

May 16, 2024

MedShape Secures $2.6M DOD Development Grant for Novel NiTiNOL Dynamic Compression Devices

Medshape reports the funding award from PRMRP includes $2.6M to complete the research milestones over the next 3 years.

August 18, 2020

Rimsys Secures $1.5 Million Investment

“Complex regulatory challenges create barriers that delay product time-to-market, stall revenue growth and increase exposure to compliance risks for even the most experienced MedTech companies, said James Gianoutsos, founder & president of Rimsys.

August 18, 2020

InnovHeart Closes Series B Financing of $24 Million

InnovHeart s.r.l., reports proceeds from the financing will be used to complete the First-in-Human clinical evaluation of the company’s unique Saturn TMVR system using a trans-apical approach.

August 7, 2020

Fractyl Raises $55 Million in Series E Financing

Fractyl reports financing was led by new investor Taiwania Capital Management Corporation and included returning investors Bessemer Venture Partners, General Catalyst, Domain Associates, Mithril Capital Management, Emergent Medical Partners, True Ventures, and GV. New investors, Catalio Capital Management, CDIB Venture Capital Corp., and YJ Capital, also participated in the round. Michael Huang, Managing Partner at Taiwania, will join Fractyl’s Board of Directors in conjunction with the financing.

August 6, 2020

Conformal Medical Gets $85M in Series C Financing

Funds will be used to support the company's U.S. pivotal trial of its novel CLAAS® Technology, a next-generation solution for sealing the left atrial appendage in patients with atrial fibrillation.

August 6, 2020

Aethlon Medical Announces Collaboration with University of Pittsburgh on NIH Grant for Head and Neck Cancer

The grant, entitled "Depleting exosomes to improve responses to immune therapy in head and neck squamous cell carcinoma" will profile the biomarkers of exosomes in patients with recurrent and metastatic head and neck cancer and will explore the impact of clinical depletion of exosomes using Aethlon's proprietary Hemopurifier device.

August 6, 2020

CardioMech AS Secures $18.5M Series A for its Transcatheter Mitral Valve Repair Technology

CardioMech AS is developing a catheter-based mitral valve repair technology as an alternative to open-heart cardiac surgery by placing its artificial chord(s) in the heart via a catheter to reduce or eliminate mitral regurgitation without opening the chest, stopping the heart, or going on heart-lung bypass.

August 5, 2020

CAPS Medical, MEDX Xelerator’s Portfolio Company, Raises $3.5 Million Series A

“CAPS was one of the first companies to join the incubator. CAPS CEO Ilan Uchitel has led his team, with the support of the incubator and its partners, to achieve all of its milestones, far ahead of schedule,” said Shai Policker, CEO of MEDX Xelerator and a CAPS Medical board member.

August 4, 2020

CytoSorbents Awarded $4.4 Million Contract by the U.S. Department of Defense

CytoSorbents reports the HemoDefend-BGA filter is designed to enable "universal plasma", or plasma that can be administered to anyone regardless of blood type, and to improve the safety of whole blood transfusions, by the rapid and efficient removal of anti-A and anti-B antibodies from these two blood products.

July 31, 2020